Tae-wook Kong

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients.

Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients.

Journal: Journal of comparative effectiveness research

Published: July 24, 2026

Corrigendum to "Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer" [Volume 208, May 2026, Pages 85-90].

Corrigendum to "Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer" [Volume 208, May 2026, Pages 85-90].

Journal: Gynecologic oncology

Published: June 13, 2026

A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3005).

A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3005).

Journal: Gynecologic oncology

Published: April 17, 2026

Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer.

Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer.

Journal: Gynecologic oncology

Published: February 25, 2026

Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.

Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.

Journal: BMC women's health

Published: November 22, 2025

Minimally invasive surgery versus open surgery in advanced stage endometrial cancer.

Minimally invasive surgery versus open surgery in advanced stage endometrial cancer.

Journal: The journal of obstetrics and gynaecology research

Published: September 06, 2024

Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).

Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).

Journal: Annals of surgical oncology

Published: March 11, 2024

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.

Journal: Journal of gynecologic oncology

Published: January 11, 2024

A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients.

A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients.

Journal: Journal of gynecologic oncology

Published: May 29, 2023

Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).

Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).

Journal: Gynecologic oncology

Published: April 26, 2023

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls.

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls.

Journal: Frontiers in oncology

Published: April 10, 2023

Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).

Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).

Journal: Cancer medicine

Published: April 04, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026